Riverwoods, IL, United States of America

Susan Elizabeth Morgan-Lappe

This inventor holds 9 USPTO granted patents and 15 published patent applications and 2 EPO patents. Top assignees: Abbvie Inc., Abbvie Biotherapeutics Inc.. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Elizabeth Morgan-Lappe. Retrieved from https://idiyas.com/inventor/susan-elizabeth-morgan-lappe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 15)

% Patents Active = 77.8

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 107(Granted Patents)

Location History:

Chicago, IL (US) (2014 - 2015)
Riverwoods, IL (US) (2016 - 2021)

Company Filing History:

Abbvie Biotherapeutics Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11045480 - Anti-huLRRC15 antibody drug conjugates and methods for their use (2021-06-29),

2. 10195209 - Anti-huLRRC15 antibody drug conjugates and methods for their use (2019-02-05),

3. 10188660 - Anti-huLRRC15 antibody drug conjugates and methods for their use (2019-01-29),

4. 9469689 - Therapeutic DLL4 binding proteins (2016-10-18),

5. 9469688 - Therapeutic DLL4 binding proteins (2016-10-18),

6. 9132190 - Therapeutic DLL4 binding proteins (2015-09-15),

7. 9115195 - Therapeutic DLL4 binding proteins (2015-08-25),

8. 9029508 - Dual variable domain immunoglobulins and uses thereof (2015-05-12),

9. 8623358 - Therapeutic DLL4 binding proteins (2014-01-07),

Title: Susan Elizabeth Morgan-Lappe: Innovator in Antibody Drug Conjugates

Introduction

Susan Elizabeth Morgan-Lappe is a prominent inventor based in Riverwoods, IL (US), known for her significant contributions to the field of biotherapeutics. With a total of 9 patents to her name, she has made remarkable strides in developing innovative treatments for cancer.

Latest Patents

Her latest patents include the development of anti-huLRRC15 antibody drug conjugates and methods for their use. These patents provide antibodies, antibody binding fragments, and antibody drug conjugates that specifically bind to human LRRC15. The methods outlined in her patents are aimed at treating patients diagnosed with cancer, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Susan has worked with notable companies such as AbbVie Inc. and AbbVie Biotherapeutics Inc. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Yingchun Li and Jonathan A Hickson, who have played a role in her research endeavors.

Conclusion

Susan Elizabeth Morgan-Lappe's innovative work in antibody drug conjugates exemplifies her dedication to improving cancer treatment. Her contributions continue to impact the field of biotherapeutics significantly.

Profile summary based on public USPTO records.